Search
for
Sort by
Research 331–360 of 714
- Intestinal Lymphatic Biology, Drug Delivery, and Therapeutics: Current Status and Future Directions
- Exploring the overlap between alopecia areata and major depressive disorder: Epidemiological and genetic perspectives
- Frontal Fibrosing Alopecia. An Example of Disrupted Aryl Hydrocarbon Receptor-Mediated Immunological Homeostasis in the Skin?
- Human Hair Follicle-Derived Mesenchymal Stromal Cells from the Lower Dermal Sheath as a Competitive Alternative for Immunomodulation
- What is behind the ‘swarm of bees’ in alopecia areata
- T-Cell Reconstitution after Thymus Xenotransplantation Induces Hair Depigmentation and Loss
- Differentiation capacity of stromal fibroblast-like cells from human bone marrow, adipose tissue, hair follicle dermal papilla and derma
- Candidate Gene Analysis Of Alopecia Areata In Jordanian Population Of Arab Descent: A Case–Control Study
- Dietary Habits in Japanese Patients with Alopecia Areata
- Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata
- Association between Mesenchymal Stem Cells and COVID-19 Therapy: Systematic Review and Current Trends
- Allogeneic Hair Transplantation with Enhanced Survival by Anti-ICAM-1 Antibody with Short-Term Rapamycin Treatment in Nonhuman Primates
- Platelet-rich plasma in the treatment of alopecia areata: A retrospective evaluation of 17 patients
- AIRE Deficiency Leads to the Development of Alopecia Areata‒Like Lesions in Mice
- Alopecia areata
- IL-15 in alopecia areata: the immune tolerance mechanistic insights and translational perspectives
- Selective blockade of γc pathway ameliorates alopecia areata in a humanized murine model
- Upadacitinib for the Management of Alopecia Totalis and Subtotalis in Pediatric Patients: A Case Series
- Tissue Retinol‐Binding Protein 4 Expression and Its Genetic Variants (rs3758539) in Patients With Severe and Treatment‐Refractory Alopecia Areata: Association With Response to Baricitinib
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- T <sub>H</sub> 1 effector CD4 T cells rely on IFN-γ production to induce alopecia areata
- Multiomics Analysis of the Response to Ritlecitinib in Alopecia Areata Subtypes and Correlation With Efficacy
- Epidermal γδ T cells, CD8 T cells and macrophages are increased in number in alopecia areata and express BST2 as part of an interferon-driven antiviral gene signature
- DISRUPTION OF HAIR FOLLICLE IMMUNE PRIVILEGE IN ALOPECIA AREATA: ENIGMATIC MECHANISMS AND EMERGING CONCEPTS
- Multi-omics analyses, cell experiments, and network pharmacology tools identified key proteins and candidate drugs for alopecia areata treatment
- Understanding the Intricate Pathophysiology of Psoriasis and Related Skin Disorders
- Exosomes: Historical Evolution and Emerging Roles in Dermatology
- The Role of Minoxidil in Treatment of Alopecia Areata: A Systematic Review and Meta-Analysis
- Pathogenesis of Alopecia Areata and Vitiligo: Commonalities and Differences
- 27 Preclinical ex vivo and in vivo evidence supporting selective inhibition of tyrosine kinase 2-dependent, IL-12-mediated signaling as a novel pharmacological strategy for alopecia areata management